|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 27 '19 | Option Exercise | 32.23 | 81,475 | 2,625,939 | 416,278 | Mar 01 07:37 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 23 '19 | Option Exercise | 21.03 | 87,449 | 1,839,052 | 388,024 | Feb 26 07:45 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 28 '18 | Option Exercise | 27.37 | 104,626 | 2,863,614 | 384,219 | Mar 02 03:44 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 24 '18 | Option Exercise | 18.90 | 91,876 | 1,736,456 | 313,499 | Feb 27 07:43 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 23 '17 | Option Exercise | 21.03 | 103,155 | 2,169,350 | 295,356 | Feb 27 06:30 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 24 '16 | Option Exercise | 18.90 | 110,981 | 2,097,541 | 274,756 | Feb 26 03:05 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Feb 25 '15 | Option Exercise | 17.69 | 101,351 | 1,792,899 | 227,982 | Feb 27 06:42 PM |
| PFE | Lewis-Hall Freda C | Executive Vice President | Sep 16 '13 | Sale | 28.70 | 38,461 | 1,103,831 | 118,383 | Sep 18 04:20 PM |
| VRTX | Lewis-Hall Freda C | EVP, Medicines Development | Mar 19 '09 | Sale | 29.11 | 1,250 | 36,388 | 53,334 | Mar 20 02:12 PM |
| VRTX | Lewis-Hall Freda C | EVP, Medicines Development | Dec 19 '08 | Sale | 29.90 | 1,250 | 37,375 | 42,500 | Dec 22 11:50 AM |
| VRTX | Lewis-Hall Freda C | EVP, Medicines Development | Dec 10 '08 | Sale | 26.00 | 152 | 3,952 | 44,848 | Dec 12 11:02 AM |
| VRTX | Lewis-Hall Freda C | EVP, Medicines Development | Dec 11 '08 | Sale | 26.00 | 1,098 | 28,548 | 43,750 | Dec 12 11:02 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite